Show simple item record

dc.contributor.authorAkar, Servet
dc.contributor.authorKalyoncu, Umut
dc.contributor.authorDalkili, Ediz
dc.contributor.authorEmmungil, Hakan
dc.date.accessioned2021-06-03T05:20:05Z
dc.date.available2021-06-03T05:20:05Z
dc.date.issued2019
dc.identifier.issn0003-4967
dc.identifier.urihttp://dx.doi.org/10.1136/annrheumdis-2019-eular.5674
dc.identifier.urihttp://hdl.handle.net/11655/23978
dc.language.isoen
dc.relation.isversionof10.1136/annrheumdis-2019-eular.5674
dc.rightsAttribution 4.0 United States
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleGo-Beyond: A Real-World Persistence Study With Golimumab In Patients With Axial Spondyloarthritis And Rheumatoid Arthritis In Turkey
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalAnnals Of The Rheumatic Diseases
dc.contributor.departmentİç Hastalıkları
dc.identifier.volume78
dc.identifier.issue2
dc.description.indexWoS


Files in this item

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 United States
Except where otherwise noted, this item's license is described as Attribution 4.0 United States